Does telemedicine actually work for chronic lung conditions?
Yes, and the evidence is surprisingly strong. The most comprehensive analysis available — a 2021 Cochrane review of 15 studies with nearly 2,000 participants — found that telerehabilitation for chronic respiratory disease (mostly COPD) produces results that are essentially the same as traditional in-person pulmonary rehabilitation [2]. For exercise capacity, measured by the 6-minute walking distance, the difference between telerehabilitation and in-person rehab was negligible (just 0.06 meters, with moderate-certainty evidence) [2]. Quality of life and breathlessness scores were also similar between the two approaches [2]. This means that for the vast majority of people with chronic respiratory conditions, doing rehab remotely is just as good as going to a clinic.
A separate meta-analysis of 26 studies (including patients with chronic respiratory diseases) confirmed that telerehabilitation significantly improved quality of life for people with chronic lung conditions compared to traditional face-to-face care [1]. The improvement was statistically significant, though modest in size [1]. Importantly, this same review found that telerehabilitation also improved self-care abilities in patients with other chronic diseases, suggesting the benefits extend beyond just lung function [1].
The biggest advantage: people actually finish the program
One of the most striking findings is that patients are far more likely to stick with telerehabilitation. The Cochrane review reported a 93% completion rate for telerehabilitation programs, compared to just 70% for in-person programs [2]. This is a huge difference — it means that for every 10 people who start a telerehabilitation program, 9 finish it, versus only 7 out of 10 for in-person rehab. The reasons are obvious: no travel, no parking, no scheduling conflicts. For people with chronic respiratory conditions who often have mobility issues or live far from a rehab center, this can be the difference between getting treatment and not getting it at all.
This higher completion rate matters because the benefits of pulmonary rehabilitation only come with consistent participation. The fact that telerehabilitation keeps more people engaged means it may actually deliver better real-world outcomes than in-person care, even if the per-session effects are similar.
What about asthma and other respiratory conditions?
The evidence for asthma is more mixed but still promising. A 2023 systematic review of telehealth for children and adolescents with asthma and cystic fibrosis found that mobile app interventions and game platforms improved adherence, quality of life, and some physiological measures compared to usual care [5]. However, the same review found that telehealth did not reduce emergency department visits, unscheduled appointments, or hospitalizations [5]. This suggests that while telehealth can help people manage their condition day-to-day, it may not prevent severe flare-ups in this younger population.
For adults with asthma, a 2025 survey of 134 patients and 180 doctors in Italy found that 85% of physicians and 74% of patients had a positive attitude toward digital tools like apps and smart inhalers [3]. Yet adoption in practice was very low — 91.5% of patients said their doctors had never recommended an app or website for asthma self-management [3]. The main barriers were concerns about data reliability (40.6% of clinicians) and knowledge gaps about the benefits of digital tools (nearly 60% of both patients and doctors) [3]. So the potential is there, but the healthcare system hasn't caught up yet.
About These Sources
This answer is built on 5 peer-reviewed studies — published from 2021 to 2025, 1 from 2024 or later, 3 in Q1 journals, collectively cited 510 times — selected as the most relevant from 6 studies that passed quality screening, drawn from 79 papers retrieved from a database of over 500 million.
Sources used in this answer
Nurse-led Telehealth Intervention for Rehabilitation (Telerehabilitation) Among Community-Dwelling Patients With Chronic Diseases: Systematic Review and Meta-analysis
In a meta-analysis of 26 studies, nurse-led telerehabilitation significantly improved quality of life for patients with chronic respiratory diseases compared to face-to-face care (standard mean difference 0.18, P=.007), with no heterogeneity between studies.
Telerehabilitation for chronic respiratory disease
This Cochrane review of 15 studies (1,904 participants, mostly COPD) found that telerehabilitation produces similar outcomes to in-person pulmonary rehabilitation for exercise capacity (6-minute walking distance difference of 0.06 meters) and quality of life, with a much higher completion rate (93% vs 70%).
Digital Innovation in Asthma Management in Italy: Results From the “Confronting Asthma Survey”
A 2025 survey of 134 asthma patients and 180 doctors in Italy found 85% of physicians and 74% of patients had a positive attitude toward digital tools, but 91.5% of patients said doctors never recommended apps for asthma self-management.
Exploring Barriers to and Enablers of the Adoption of Information and Communication Technology for the Care of Older Adults With Chronic Diseases: Scoping Review
A scoping review of 31 studies (4,185 participants) found that ICT interventions for older adults with chronic diseases, including chronic respiratory disease, showed positive effects on self-management, but barriers included knowledge gaps and reluctance to adopt new technologies.
Telehealth for children and adolescents with chronic pulmonary disease: systematic review.
A systematic review of 12 trials in children and adolescents with asthma and cystic fibrosis found that mobile apps and game platforms improved adherence and quality of life, but did not reduce emergency visits or hospitalizations.